Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02228044
Other study ID # 5970
Secondary ID R01AA016854
Status Completed
Phase N/A
First received August 25, 2014
Last updated August 26, 2014
Start date September 2008
Est. completion date March 2014

Study information

Verified date August 2014
Source George Mason University
Contact n/a
Is FDA regulated No
Health authority United States: George Mason University Human Subjects Review BoardUnited States: National Institute on Alcohol Abuse and Alcoholism
Study type Interventional

Clinical Trial Summary

This study examines whether an integrated alcohol/substance abuse, suicide, and HIV prevention protocol is associated with lower onset and frequency of alcohol and other drug use, suicidal behavior, and high risk sexual behavior among adolescents receiving community based mental health care.


Description:

The purpose of this study is to compare an integrated adolescent alcohol/drug, suicide, and HIV prevention program to an assessment only control condition in a randomized clinical trial. This prevention protocol is designed as an "add-on" intervention to standard mental health care. We will examine the extent to which the addition of this prevention protocol is associated with lower rates of alcohol use and drug use, suicidal behavior, and HIV related risk behaviors.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria:

- ages 13-18

- English speaking adolescent and at least one English speaking parent

- receiving mental health treatment

- living with a parent or guardian willing to participate

Exclusion Criteria:

- Active Alcohol or Marijuana Dependence Diagnosis

- HIV infection

- Pregnant

- Current psychosis

- Cognitively unable to give assent

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Prevention program


Locations

Country Name City State
United States George Mason University Fairfax Virginia

Sponsors (2)

Lead Sponsor Collaborator
George Mason University National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary adolescent alcohol use and binge drinking (any, number of days, number of related problems) This was assessed using the Customary Drinking and Drug Use Record change from baseline to 6 months (prior 3 months) No
Primary adolescent suicidal ideation and behavior (severity of suicidal ideation and presence of any suicidal ideation or suicidal behavior) This was assessed using the Suicidal ideation Questionnaire and the Self-Injurious Thoughts and Behavior Interview change from baseline to 6 months (prior month to 6 months) Yes
Primary adolescent HIV risk behavior (any sexual behavior, number of sexual partners, number of unprotected sexual acts) This was assessed using the Adolescent Risk Behavior Assessment. change from baseline to 6 months (prior 3 months) No
Primary adolescent marijuana use (any use, number of days, related problems) This was assessed with the Customary Drinking and Drug Use Measure change from baseline to 6 months (prior 3 months) No
Primary adolescent alcohol use and binge drinking (any, number of days, number of related problems) This was assessed using the Customary Drinking and Drug Use Measure change from baseline to 12 months (prior 3 months) No
Primary adolescent suicidal ideation and behavior (severity of suicidal ideation and presence of any suicidal ideation or suicidal behavior) This was assessed with the Suicidal Ideation Questionnaire and the Self-Injurious Thoughts and Behavior Questionnaire change from baseline to 12 months (prior month to 6 months) Yes
Primary adolescent HIV risk behavior (any sexual behavior, number of sexual partners, number of unprotected sexual acts) This was assessed with the Adolescent Risk Behavior Assessment change from baseline to 12 months (prior 3 months) No
Primary adolescent marijuana use (any use, number of days, related problems) This was assessed with the Customary Drinking and Drug Use Record change from baseline to 12 months (prior 3 months) No
Secondary frequency of parental monitoring behavior This was assessed with the Parental Monitoring Questionnaire change from baseline to 1 month No
Secondary quality of parent-child communication around high risk behaviors This was assessed with the Parent-Adolescent Sexual Communication Scale and items adapted for alcohol/drug use and suicidal behavior change from baseline to 1 month No
Secondary adolescent perceptions of parental degree of disapproval of high risk behavior This was assessed with Parental Norms for Sexual Activity and Supervision Scale and items adapted for alcohol/drug use change from baseline to 1 month No
Secondary adolescent perception of degree of interpersonal coping and stress management skills This was assessed with the Bar-On Emotional Quotient Inventory - Youth Version change from baseline to 6 months No
Secondary adolescent degree of perceived self-efficacy for condom use This was assessed with the Self-Efficacy for Condom Use Scale change from baseline to 1 month No
Secondary adolescent degree of HIV related knowledge This was assessed with the HIV Knowledge Scale change from baseline to 1 month No
Secondary adolescent perceptions of degree of peer substance use and tolerance of use This was assessed with Peer Substance Use and Tolerance of Use scale change from baseline to 6 months No
Secondary adolescent perception of the degree of peer approval of sexual activity This was assessed with the Peer Norms Scale for Sexual Activity scale change from baseline to 6 months No
Secondary adolescent degree of perceived self-efficacy for HIV prevention This was assessed with the Self-Efficacy for HIV Prevention Scale change from baseline to 1 month No
Secondary frequency of positive and negative thoughts related to suicide This was assessed with the Positive and Negative Suicide Ideation Inventory change from baseline to 1 month Yes
Secondary degree of adolescent positive/negative attitudes and beliefs about alcohol This was assessed with the Youth Alcohol and Drug Survey change from baseline to 1 month No
Secondary degree of adolescent positive/negative attitudes and beliefs about marijuana use This was assessed with the Youth Alcohol and Drug Survey change from baseline to 1 month No
Secondary frequency of parental monitoring behavior This was assessed with the parental monitoring questionnaire change from baseline to 6 months No
Secondary frequency of parental monitoring behavior This was assessed with the parental monitoring questionnaire change from baseline to 12 months No
Secondary quality of parent-child communication around high risk behaviors This was assessed with the Parent-Adolescent Sexual Communication Scale and items adapted for alcohol/drug use and suicidal behavior change from baseline to 6 months No
Secondary quality of parent-child communication around high risk behaviors This was assessed with the Parent-Adolescent Sexual Communication Scale and items adapted for alcohol/drug use and suicidal behavior change from baseline to 12 months No
Secondary adolescent perceptions of parental degree of disapproval of high risk behavior This was assessed with Parental Norms for Sexual Activity and Supervision Scale and items adapted for alcohol/drug use change from baseline to 6 months No
Secondary adolescent perceptions of parental degree of disapproval of high risk behavior This was assessed with Parental Norms for Sexual Activity and Supervision Scale and items adapted for alcohol/drug use change from baseline to 12 months No
Secondary adolescent perception of degree of interpersonal and stress management coping skills This was assessed with the Bar-On Emotional Quotient Inventory - Youth Version change from baseline to 12 months No
Secondary adolescent perceptions of degree of peer substance use and approval of use This was assessed with Peer Substance Use and Tolerance of Use scale change from baseline to 12 months No
Secondary adolescent perception of the degree of peer approval of sexual activity This was assessed with the Peer Norms Scale for Sexual Activity scale change from baseline to 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2